Pet DNA Testing Market Outlook from 2025 to 2035

The Pet DNA Testing Market is valued at USD 419.48 million in 2025. As per FMI's analysis, the Pet DNA Testing Market will grow at a CAGR of 9.1% and reach USD 916.43 million by 2035. The future is bright for the industry beyond 2025 as it rides on the tide of continuous steady growth.

Some of the emerging trends include precision medicine for pets, dietary programs based on specific breeds, and collaborations between clinics and DNA-testing organizations. Moreover, wearable pet health monitors will incorporate preventive care paradigm shift. The high-end testing services are also likely to be affected by pressure on prices, but continued technological improvements will keep pushing industry growth and make DNA tests synonymous with modern pet care.

The developments that were observed in the pet DNA testing Market increased during the year 2024 due to the rising ownership of pets and the growing awareness of consumers about pet genetics and advances in biotechnology. Thus, companies mainly focused on improving test accuracy and increasing breed identification databases to meet the increasing demand for personalized pet healthcare solutions.

Integration of artificial intelligence (AI) in genetic analysis streamlined the tracking of ancestry and the prediction of health predispositions. Furthermore, expansion into DTC testing by important companies has been made possible through various e-commerce channels for improved access.

North America was the industry leader, but the Asia-Pacific region was one of the growth areas experiencing increasing demand through urbanization accompanied by an increase in expenditure on pet care. However, obstacles to some possible regions include regulatory uncertainties and data privacy issues.

Metric Value
Industry Value (2025E) USD 419.48 million
Industry Value (2035F) USD 916.43 million
CAGR (2025 to 2035) 9.1%

Explore FMI!

Book a free demo

Market Analysis

As pet humanization rises and demand for personalized healthcare continues to grow along with technological improvements in genetic diagnostics, the pet DNA testing industry will track upward.

Direct-to-consumer testing companies, veterinary partners and research institutions stand to gain, while more traditional pet care providers who are ill-equipped to respond will struggle. As genetic perspectives become a main feature of pet wellness, regulatory specificity and new affordable innovations will dictate the trajectory of the industry in the long term.

Segment Wise Analysis

By Animal

As pet owners seek more information about breed ancestry, potential genetic disorders, and personalized healthcare recommendations, dogs will remain the dominant species in the pet DNA testing industry. The increasing trend of dog adoption and demand for premium pet care services will boost the demand for DNA testing among purebred as well as mixed-breed dog owners.

Breed profiling and health screening will be a key tool within canine healthcare practice to help steer diagnosis for hereditary conditions and nutrition plans. You will also see a larger share of the industry going to cats, especially as feline genetic testing expands beyond just the identification of a breed to assess health and wellness.

Growing awareness on part of the cat owners regarding genetic pre-dispositions to diseases such as polycystic kidney disease (PKD) and hypertrophic cardiomyopathy (HCM) will act as a key driver for the adoption rates. While dogs remain the dominant revenue source, an increased focus on feline genetics and advancements in testing methods will significantly contribute to the long-term growth of the overall industry.

By Sample

In veterinary clinics and breeding facilities, blood samples will continue to be the gold standard when it comes to high-accuracy genetic testing. With blood working their significant insights into hereditary conditions and health hazards, these sorts of tests are essential for breeders and veterinarians with a preventive will to wellbeing.

Given the benefits of minimally invasive, user-friendly kits for at-home testing, saliva-based testing will lead the direct-to-consumer segment. The reason saliva is used the most in consumer-focused DNA testing is that it is the best biological sample for general breed identification and genetic scanning. It told that semen testing will remain a niche segment, only targeted at professional breeders, like racehorses, who wish to continue genetically screened breeding.

As technology continues its rapid advancement, more alternatives are going to develop. Hair and tissue testing will probably gain popularity as well to provide even further comprehensive testing covering common genetic traits. The typical industry drivers will continue to be saliva and blood samples, as the quality and convenience improve over time.

By Test

Based on the test type, the genetic diseases segment held the leading share of 35.0% in 2025. Breed profiling will be the most widely adopted DNA test, as pet owners seek to understand their pet’s genetic heritage and unique traits.

This segment will be driven by curiosity-driven consumers and those adopting mixed-breed pets. Genetic disease testing will see increased adoption as owners and veterinarians use DNA insights to detect predispositions to inherited conditions early, enabling proactive health interventions. Health and wellness testing will emerge as a key growth area, offering insights into nutritional needs, exercise compatibility, and metabolic tendencies based on genetic markers.

As personalized pet care gains momentum, demand for all three test types will rise, with companies focusing on integrating multiple test types into comprehensive genetic screening packages. The convergence of breed profiling, genetic disease analysis, and wellness insights will make DNA testing an essential tool for pet healthcare over the forecast period.

By End-user

Based on end users, the breeder segment flourishes at a CAGR of 8.9% between 2025 and 2035 Pet owners will remain the primary consumers of DNA testing kits, fueling industry growth through direct-to-consumer purchases. Increasing pet humanization and growing concerns about pet longevity will drive higher adoption of genetic screening for health management.

Breeders will continue to rely on DNA testing for selective breeding programs, ensuring the health and genetic purity of pedigree animals. The demand for genetic testing among breeders will remain steady, particularly as breed-specific health concerns become more widely recognized.

Veterinarians will play a crucial role in the expansion of the pet DNA testing industry, integrating genetic diagnostics into routine health assessments and treatment plans. Veterinary clinics will increasingly recommend DNA testing as a preventive healthcare measure, strengthening partnerships with testing service providers. As the ecosystem of pet care evolves, the collaboration between pet owners, breeders, and veterinarians will shape the future of the pet DNA testing industry.

Top 3 Strategic Imperatives for Stakeholders

Invest in AI-Driven Genetic Insights

Executives should prioritize R&D in AI-enhanced genetic analysis to improve test accuracy and predictive health modeling. By integrating machine learning with DNA databases, companies can provide more precise ancestry tracking and risk assessments, differentiating their offerings in a competitive industry.

Expand Direct-to-Consumer & Veterinary Partnerships

Aligning with shifting consumer behavior, stakeholders must strengthen their e-commerce presence and forge deeper collaborations with veterinary clinics. This will ensure wider adoption through trusted healthcare providers while capitalizing on the growing trend of pet wellness subscriptions and personalized care plans.

Scale Manufacturing & Strengthen Data Security

Companies should invest in scaling production capacity to meet rising demand while ensuring compliance with evolving data privacy regulations. Securing partnerships with logistics providers and refining supply chain strategies will be critical to maintaining service reliability and protecting sensitive pet-owner data.

Risks Stakeholders Should Monitor

Risk Probability - Impact
Regulatory uncertainty around pet genetic data Medium - High
Consumer skepticism about test accuracy High - Medium
Market saturation leading to price competition Medium - High

1-Year Executive Watchlist

Priority Immediate Action
Strengthen AI-powered genetic predictions Expand partnerships with biotech firms and invest in predictive analytics
Improve direct-to-consumer engagement Launch digital industrying initiatives and loyalty-based subscription models
Expand international footprint Conduct feasibility studies for industry entry into Asia-Pacific and Latin America

For the Boardroom

The pet DNA testing industry is shifting from a curiosity-driven niche to an essential tool in preventive pet healthcare. To stay ahead, companies must integrate AI for precision testing, deepen veterinarian partnerships, and enhance data security.

A forward-looking roadmap should include scaling global operations, investing in consumer education, and leveraging subscription-based models for recurring revenue. Executives should act decisively to turn pet genetics into a mainstream, indispensable segment of the broader pet wellness ecosystem.

FMI Survey & Expert Interviews

FMI Survey Results: Pet DNA Testing Market Dynamics Based on Stakeholder Perspectives

Surveyed Q4 2024, n=500 stakeholder participants evenly distributed across manufacturers, distributors, veterinarians, pet breeders, and pet owners in the US, Western Europe, Japan, and South Korea

Key Priorities of Stakeholders

  • Accuracy & Reliability: 85% of stakeholders globally identified the accuracy of genetic results as a "critical" priority, with concerns over false positives and inconclusive outcomes.
  • Affordability: 72% of respondents cited cost reductions as a key factor to increase adoption, particularly in emerging pet industries.

Regional Variance:

  • USA: 65% of pet owners emphasized ease of use and fast turnaround time, preferring saliva-based home testing kits.
  • Western Europe: 82% prioritized ethical considerations, including data privacy, genetic diversity conservation, and sustainable testing methods.
  • Japan/South Korea: 58% of veterinarians highlighted the need for regulatory clarity on pet genetic data usage, as opposed to 29% in the US.

Embracing Sophisticated Technologies

High Variance:

  • USA: 60% of veterinarians have started integrating AI-powered genetic risk prediction tools into pet healthcare plans.
  • Western Europe: 55% of genetic testing providers are incorporating blockchain technology to ensure data security and pet ancestry traceability.
  • Japan: Only 26% of pet owners opted for advanced DNA services, citing skepticism and limited awareness about genetic testing benefits.
  • South Korea: 42% of breeders invested in next-generation sequencing (NGS) to refine genetic matching in pedigree breeding programs.

Convergent and Divergent Perspectives on ROI:

  • 69% of USA pet owners determined that genetic health screening is "worth the investment," whereas only 35% in Japan saw a strong value proposition.

Sample Type Preferences

Consensus:

  • Saliva: Preferred by 71% of respondents due to non-invasive collection and high consumer accessibility.

Variance:

  • Western Europe: 53% of veterinarians prefer blood-based testing for higher accuracy in disease risk profiling, compared to 39% globally.
  • Japan/South Korea: 48% of breeders favored semen sample testing for reproductive genetics, particularly in high-value breeding programs.
  • USA: 68% of pet owners opted for saliva-based testing, but 21% of specialty clinics have adopted tissue biopsies for in-depth genetic analysis.

Price Sensitivity

Shared Challenges:

  • 81% of stakeholders cited the rising costs of genomic sequencing as a barrier to wider adoption.

Regional Differences:

  • USA/Western Europe: 59% of pet owners were willing to pay a 20-30% premium for bundled DNA testing services, including breed profiling and health risk assessment.
  • Japan/South Korea: 76% of respondents preferred more affordable testing kits (< USD 50) and showed resistance to premium-priced offerings.
  • South Korea: 48% of breeders supported leasing genetic testing services on a subscription model to reduce upfront costs, compared to 22% in the US.

Pain Points in the Value Chain

Manufacturers:

  • USA: 52% struggled with rising costs of advanced sequencing technologies.
  • Western Europe: 47% cited complex compliance requirements under GDPR for pet genetic data privacy.
  • Japan: 58% struggled with weak consumer awareness, limiting industry penetration.

Distributors:

  • USA: 68% experienced supply chain delays in reagent and testing kit imports.
  • Western Europe: 54% faced competition from cheaper, unregulated genetic testing providers from Eastern Europe.
  • Japan/South Korea: 61% cited logistical difficulties in last-mile delivery to remote pet clinics.

End Users (Pet Owners, Breeders, Veterinarians):

  • USA: 41% of pet owners complained about unclear test result interpretations.
  • Western Europe: 38% of veterinarians cited challenges in integrating genetic insights into treatment protocols.
  • Japan: 55% of pet owners cited a lack of customer support for complex DNA test reports.

Future Investment Priorities

Alignment:

  • 76% of global genetic testing companies plan to invest in AI-driven genetic interpretation tools.

Divergence:

  • USA: 62% in expanding direct-to-consumer platforms with personalized health reports.
  • Western Europe: 58% in eco-friendly and bio-based test kit materials to enhance sustainability.
  • Japan/South Korea: 50% in microarray technology for high-speed, cost-effective genetic screening.

Regulatory Impact

  • USA: 66% of industry players expressed concern over potential FDA oversight on direct-to-consumer pet DNA testing.
  • Western Europe:79% saw upcoming EU data privacy regulations as a key factor shaping genetic testing transparency.
  • Japan/South Korea: Only 31% felt that existing regulations significantly impacted purchasing decisions, citing minimal enforcement.

Conclusion: Variance vs. Consensus

High Consensus: Data accuracy, cost pressures, and regulatory uncertainty are critical issues for global stakeholders.

Key Variances:

  • USA: Growth driven by AI-driven analytics vs. Japan/South Korea: Demand limited by cost sensitivity and consumer skepticism.
  • Western Europe: Leading in sustainability and ethical testing vs. Asia: Prioritizing affordability and hybrid sampling methods.

Strategic Insight:

  • A standardized approach will not work. Companies must tailor pricing models, technology investments, and compliance strategies based on regional demands to maximize industry penetration.

Regulatory Impact on the Pet DNA Testing Market

Country/Region Regulatory Impact & Mandatory Certifications
United States The FDA and USDA have started evaluating the need for regulatory oversight of pet genetic testing, particularly for direct-to-consumer (DTC) kits. The Animal and Plant Health Inspection Service (APHIS) requires breeders to comply with genetic health screening for certain conditions. Data privacy laws, such as CCPA (California Consumer Privacy Act), may affect genetic data collection.
Western Europe The General Data Protection Regulation (GDPR) enforces strict guidelines on pet genetic data storage and processing. The European Pet Food Industry Federation (FEDIAF) encourages voluntary compliance with genetic testing standards for breed identification. Veterinary authorities in Germany and France are pushing for mandatory genetic screening of breeding stock to prevent hereditary diseases.
United Kingdom Post-Brexit, the UK has separate regulatory frameworks under the Data Protection Act 2018, which impacts pet genetic data handling. The Kennel Club of the UK has introduced guidelines for breeders to conduct genetic tests before registration. DEFRA (Department for Environment, Food & Rural Affairs) is reviewing potential certification for genetic testing laboratories.
Japan The government does not have strict pet genetic testing regulations, but the Act on the Protection and Management of Animals encourages responsible breeding practices. The Japan Kennel Club (JKC) promotes voluntary genetic health certification for registered breeders. Personal Data Protection Laws may impact how companies collect and store pet genetic information.
South Korea The Korean Animal Protection Act is evolving to include ethical breeding regulations, potentially mandating DNA testing for high-value breeds. The Korean Veterinary Medical Association (KVMA) is working with regulatory bodies to create certification standards for pet genetic laboratories. Genetic data handling must comply with Personal Information Protection Act (PIPA) regulations.
China The China Ministry of Agriculture and Rural Affairs has introduced preliminary guidelines for genetic testing in the livestock sector, but pet DNA testing remains largely unregulated. However, stricter import regulations for genetic testing kits are emerging, affecting foreign companies entering the industry. Data localization laws could require genetic testing companies to store pet genetic data within China.
Australia The Australian Veterinary Association (AVA) is considering standardized DNA testing requirements for registered breeders. The Privacy Act 1988 may impact genetic data storage, particularly for consumer DNA test kits. Some states, like Victoria, have proposed mandatory health screening for dogs used in breeding programs.

Market Share Analysis of Leading Companies

Company Name Market Share (%) & Competitive Positioning
Embark Veterinary, Inc. 35.2% - Market leader with a strong direct-to-consumer (DTC) model, advanced genetic research, and key partnerships with breeders and veterinarians. Expanded international presence.
Wisdom Panel (Mars, Inc.) 28.5% - Major competitor with one of the largest breed databases. Strengthened position in Europe and Asia-Pacific through acquisitions and expanded veterinary partnerships.
Orivet Genetic Pet Care 12.1% - Niche player focusing on customized genetic reports and veterinary-endorsed solutions. Gained traction through pet insurance integrations and B2B collaborations.
DNA My Dog 8.3% - Strong in the affordable pet DNA testing segment, leveraging retail partnerships and simplified genetic reports. Growing customer base in North America.
Neogen Corporation 7.6% - Primarily focused on agricultural and livestock genetic testing but gaining traction in companion animal DNA testing. Strong B2B focus.
Basepaws (Zoetis-owned) 5.5% - Leader in feline genetic testing with a focus on preventive pet healthcare. Expanding presence in Asia-Pacific and developing microbiome testing solutions.
GenSol Diagnostics 2.8% - Small but growing player in targeted genetic disease testing for breeders. Leveraging online sales and veterinary partnerships for growth.

Key Developments in 2024

Embark Veterinary, Inc.

  • Formed a strategic partnership with the American Kennel Club (AKC) to enhance breed-specific genetic health research.
  • Expanded operations into Japan and South Korea through new distribution agreements.

Wisdom Panel (Mars, Inc.)

  • Launched an AI-powered genetic counseling platform for pet owners and veterinarians.
  • Acquired a European pet DNA testing startup, solidifying its foothold in the region.

Orivet Genetic Pet Care

  • Partnered with major pet insurance companies to integrate genetic risk assessments into policy pricing.
  • Expanded its vet-exclusive product line for genetic wellness screening.

Country-wise Analysis

United States

The pet DNA testing industry in the USA is projected to grow at a CAGR of approximately 9.5% from 2025 to 2035, driven by increasing pet humanization and rising interest in genetic health screening. The country has one of the highest pet ownership rates globally, with an expanding population of dog and cat owners seeking DNA testing services.

Major players such as Embark Veterinary and Wisdom Panel dominate the industry, leveraging direct-to-consumer (DTC) sales channels and partnerships with veterinarians. The growing role of genetic testing in preventive pet healthcare is fueling demand, as pet owners become more aware of breed-specific health risks and hereditary diseases.

Additionally, pet insurance companies are increasingly integrating DNA testing into their policies, encouraging early detection of genetic conditions. The regulatory environment in the USA remains relatively open, though potential future concerns around genetic data privacy could influence industry dynamics.

Online retail platforms such as Amazon and Chewy are key sales channels, accounting for a significant portion of revenue. The trend toward at-home testing kits is expected to persist, with advancements in DNA sequencing technology improving test accuracy and affordability. Continued research into pet genetics and personalized wellness solutions will likely drive sustained industry expansion in the coming decade.

United Kingdom

The pet DNA testing industry in the UK is expected to register a CAGR of approximately 8.8% from 2025 to 2035, supported by strong animal welfare regulations and a growing focus on responsible breeding practices. The country has a well-established culture of pet care, with pet owners increasingly seeking genetic insights to ensure the long-term health of their animals.

Breed identification and hereditary disease screening are the primary applications driving industry growth, particularly among dog and cat owners. Veterinary clinics and breeders are playing a key role in promoting DNA testing, with many integrating genetic screening into standard health check-ups.

The Kennel Club and other regulatory bodies emphasize ethical breeding, which is increasing the adoption of genetic tests among breeders. Additionally, growing concerns about inbreeding and hereditary disorders in pedigree breeds have heightened demand for comprehensive genetic testing solutions.

E-commerce platforms and pet specialty retailers are expanding their offerings of DNA testing kits, making these services more accessible. The increasing availability of advanced genetic screening, including whole-genome sequencing for pets, is expected to drive further industry adoption. As UK pet owners continue prioritizing their pets' health and longevity, the demand for high-accuracy, user-friendly DNA testing solutions is set to rise.

France

The pet DNA testing industry in France is projected to grow at a CAGR of approximately 8.5% from 2025 to 2035, driven by rising pet ownership and growing consumer interest in pet health and wellness. France has a strong culture of pet care, with increasing emphasis on preventive healthcare solutions, including genetic testing. Pet owners are becoming more informed about breed-related diseases, which is fueling demand for DNA-based screening services.

Veterinary professionals and pet insurance providers are playing an active role in expanding the industry by recommending DNA tests for early disease detection. French breeders are also adopting genetic testing to ensure healthier breeding practices, particularly for pedigree dogs and cats. However, consumer awareness remains a key challenge, as many pet owners are still unfamiliar with the benefits of DNA testing.

Germany

The pet DNA testing industry in Germany is expected to expand at a CAGR of approximately 9.0% from 2025 to 2035, supported by strong consumer awareness, stringent breeding regulations, and technological advancements in genetic testing. Germany has one of the most developed pet care industries in Europe, with a high level of pet ownership and a strong emphasis on animal welfare.

The country's well-established veterinary infrastructure is driving increased adoption of DNA testing, particularly for breed identification and hereditary disease screening. Breeders are actively using genetic tests to minimize the risk of inherited disorders, while pet owners are turning to DNA testing for personalized healthcare insights. Regulatory bodies in Germany promote responsible breeding practices, further fueling demand for genetic testing solutions.

Italy

The pet DNA testing industry in Italy is anticipated to grow at a CAGR of approximately 8.3% from 2025 to 2035, driven by increasing pet adoption rates and rising consumer awareness of genetic health testing. Italy has a long-standing tradition of pet care, with an increasing number of pet owners seeking advanced healthcare solutions for their animals.

Breed identification and genetic disease screening are among the primary applications fueling industry demand. Veterinarians are becoming key promoters of genetic testing, encouraging pet owners to use DNA tests for preventive health measures. The rise in pet humanization, where pets are considered family members, has led to increased spending on advanced wellness solutions, including genetic screening.

New Zealand

The pet DNA testing industry in New Zealand is expected to grow at a CAGR of approximately 7.9% from 2025 to 2035, supported by a strong pet ownership culture and increasing demand for pet health insights. New Zealanders have a deep attachment to their pets, leading to a rise in spending on premium pet care services, including DNA testing.

Breeders and veterinarians are adopting genetic testing to ensure responsible breeding practices and early detection of hereditary conditions. Pet owners are increasingly turning to DNA tests to understand their pets' breed history, health risks, and behavioral traits. The industry is still in its early stages compared to North America and Europe, but awareness is growing rapidly.

South Korea

The pet DNA testing industry in South Korea is projected to expand at a CAGR of approximately 9.2% from 2025 to 2035, driven by a booming pet care industry and rising consumer demand for premium pet healthcare solutions. South Korea has one of the fastest-growing pet ownership rates in Asia, with pet parents increasingly prioritizing their pets' health and well-being.

Veterinary clinics and pet wellness centers are playing a crucial role in expanding genetic testing adoption. Breed identification and health screening tests are gaining popularity among dog and cat owners, particularly in urban areas. The trend toward pet humanization has led to increased spending on high-quality pet products, including DNA testing kits.

Japan

The pet DNA testing industry in Japan is projected to grow at a CAGR of approximately 7.6% from 2025 to 2035, supported by the rising pet humanization trend and an aging population that increasingly treats pets as family members. While Japan has a lower pet ownership rate compared to Western industries, the country’s premium pet care segment is expanding, driving demand for advanced healthcare solutions like DNA testing.

Breed identification and hereditary disease screening are key drivers, with small breed dogs being the most common test subjects. Japanese consumers are highly meticulous about their pets' health, and the demand for customized pet nutrition based on genetic insights is growing. However, industry penetration remains lower than in the USA and Europe due to relatively limited awareness of genetic testing benefits.

China

The pet DNA testing industry in China is anticipated to expand at a CAGR of approximately 10.1% from 2025 to 2035, making it one of the fastest-growing industries globally. The rapid rise in pet ownership, particularly among urban millennials and Gen Z, is a key driver of industry growth. Increasing disposable incomes and a growing willingness to invest in pet healthcare are fueling demand for genetic testing services.

China's industry is dominated by local brands and emerging startups, many of which offer DNA testing as part of broader pet wellness services. The demand for breed verification is particularly high due to concerns over mixed-breed pets being sold as purebred. Additionally, rising awareness of hereditary diseases and customized pet nutrition is further boosting the industry.

Australia

The pet DNA testing industry in Australia is expected to grow at a CAGR of approximately 8.7% from 2025 to 2035, driven by high pet ownership rates and strong consumer interest in pet health and well-being. Australia has one of the highest pet ownership rates in the world, with nearly two-thirds of households owning a pet, making it a lucrative industry for DNA testing services.

Breed identification and hereditary disease screening are key market drivers, with veterinarians actively promoting DNA testing as part of routine pet healthcare. Ethical breeding practices are also a major focus, with breeders increasingly using genetic tests to ensure responsible breeding. The Australian government has strict regulations on pet imports, increasing the demand for genetic verification services.

Key Players

  • Wisdom Panel
  • Orivet Genetic Pet Care Ltd.
  • Embark Veterinary, Inc.
  • Dognomics
  • DNA MY DOG
  • Basepaws, Inc.
  • Neogen Corp.
  • GenSol Diagnostics, LLC
  • FidoCure
  • PetDx

Frequently Asked Questions

What is driving the growth of pet DNA testing services worldwide?

The increasing awareness among pet owners about genetic health risks, rising demand for personalized pet care, and advancements in DNA testing technology are major factors contributing to the expansion of pet DNA testing services.

How do pet DNA tests benefit veterinarians and breeders?

Veterinarians use DNA tests to diagnose genetic diseases early, allowing for proactive health management, while breeders rely on them to ensure responsible breeding practices and prevent hereditary disorders.

Which types of DNA tests are most used for pets?

The most popular tests include breed identification, genetic disease screening, and health & wellness assessments, all of which provide insights into a pet’s ancestry and potential health risks.

Are there any regional differences in the adoption of pet DNA testing?

Yes, North America and Europe have the highest adoption rates due to advanced veterinary infrastructure and high pet ownership rates, while Asia-Pacific is emerging as a fast-growing region due to increasing pet humanization trends.

What are the key factors pet owners consider before purchasing a DNA test for their pets?

Accuracy of results, affordability, ease of sample collection, and the depth of genetic information provided are among the top considerations for pet owners when choosing a DNA test for their pets.

Table of Content
  1. Executive Summary
  2. Market Overview
  3. Market Background
  4. Global Market Analysis 2020 to 2024 and Forecast, 2025 to 2035
  5. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Animal Type
    • Dogs
    • Cats
  6. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Sample Type
    • Blood
    • Saliva
    • Semen
    • Others
  7. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Test Type
    • Breed Profile
    • Genetic Diseases
    • Health & Wellness
  8. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By End-user
    • Pet Owners
    • Breeders
    • Veterinarians
  9. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Region
    • North America
    • Latin America
    • Europe
    • South Asia
    • East Asia
    • Oceania
    • MEA
  10. North America Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
  11. Latin America Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
  12. Europe Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
  13. South Asia Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
  14. East Asia Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
  15. Oceania Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
  16. MEA Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
  17. Key Countries Market Analysis
  18. Market Structure Analysis
  19. Competition Analysis
    • Wisdom Panel
    • Orivet Genetic Pet Care Ltd.
    • Embark Veterinary, Inc.
    • Dognomics
    • DNA MY DOG
    • Basepaws, Inc.
    • Neogen Corp.
    • GenSolDiagnostics, LLC
    • FidoCure
    • PetDx
  20. Assumptions & Acronyms Used
  21. Research Methodology

Pet DNA Testing Market Segmentation

By Animal Type:

  • Dogs
  • Cats

By Sample Type:

  • Blood
  • Saliva
  • Semen
  • Others

By Test Type:

  • Breed Profile
  • Genetic Diseases
  • Health & Wellness

By End User:

  • Pet Owners
  • Breeders
  • Veterinarians

By Key Regions:

  • North America
  • Latin America
  • Europe
  • Japan
  • Asia Pacific Excluding Japan (APEJ)
  • Middle East & Africa

Explore Healthcare Insights

Eyelid Scrub Market

Eyelid Scrub Market Analysis & Forecast by Product, Application and Region 2025 to 2035

Protein Diagnostics Market

Protein Diagnostics Market Share, Size and Forecast 2025 to 2035

CGRP Inhibitors Market

CGRP Inhibitors Market Trends - Growth, Demand & Forecast 2025 to 2035

Indolent Systemic Mastocytosis treatment Market

Indolent Systemic Mastocytosis treatment Market Insights: Size, Trends & Forecast 2025 to 2035

Intraoperative Fluorescence Imaging Market

Intraoperative Fluorescence Imaging Market Report - Demand, Trends & Industry Forecast 2025 to 2035

Lung Cancer PCR Panel Market

Lung Cancer PCR Panel Market Trends, Growth, Demand & Forecast 2025 to 2035

Future Market Insights

Pet DNA Testing Market